Innovative Transfusion Medicine Inc (EIN 830904582) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2018

Legal Domicile

Principal Officer

Robert Mckie

Phone

9545316335

Tax Period

2023-01-01 to 2023-12-31

Innovative Transfusion Medicine Inc, founded in 2018, is a community nonprofit in the Health Care sector that reported $7.8M in total revenue in fiscal year 2023. Revenue grew 10% year-over-year, indicating healthy expansion. Expenses of $11.6M exceeded revenue, resulting in a 49% operating deficit.

Mission

IMPROVE HEALTH COMMUNITY THROUGH WORK AND RESEARCH WITH BLOOD AND BLOOD PRODUCTS.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $0

Program Service Revenue $10,984,944

Investment Income $-3,444,657

Other Revenue $224,562

TOTAL REVENUE $7,764,849

Expense Breakdown

Grants Paid $0

Salaries & Benefits $1,290,793

Fundraising Expenses $0

Program Expenses $10,696,785

Other Expenses $10,272,517

TOTAL EXPENSES $11,563,310

Year-over-Year Comparison

	2023	2022	Change
Revenue	$7,764,849	$7,069,661	+0.1%
Expenses	$11,563,310	$8,287,167	+0.4%
Net Income	$-3,798,461	$-1,217,506	+2.1%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$119,000

Total Directors

$174,064

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
ROBERT MCKIE	CHIEF FINANCIAL OFFICER	35.0	Officer Director	$0	$60,000	$60,000
ENRIQUE SOTOLONGO	CHIEF OPERATIONS OFFICER	3.0	Officer Director	$59,000	$0	$59,000
DR ARCADIO OLIVA	MEDICAL DIRECTOR	3.0	Director	$55,064	$0	$55,064
GREGORY CHIKLIS	MEMBER	3.0	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2023	$7,764,849	$11,563,310	$530,025	$-3,798,461
2022	$7,069,661	$8,287,167	$6,363,122	$-1,217,506
2021	$41,552,267	$37,430,258	$6,723,913	$4,122,009
2020	$13,767,822	$12,709,860	$13,159,836	$1,057,962
2019	$1,351,083	$1,320,957	$2,452,686	$30,126
2018	$496,633	$395,013	$537,277	$101,620

Innovative Transfusion Medicine Inc